Development of octanol membranes for drug screening

  • Thorsteinn Loftsson
  • Fífa Konrádsdóttir
  • Már Másson
Original Article

Abstract

Most drugs permeate biological membranes via passive diffusion and it is generally assumed that the main barrier is the lipophilic structure of the membranes. However, it has been observed that an unstirred water layer adjacent to the membrane surface can in some cases be just as effective barrier as the lipophilic membrane itself. Hydrophilic cyclodextrins can enhance drug delivery through biological membranes by increasing the availability of dissolved drug molecules immediate to the membrane surface, i.e., by increasing drug delivery through the unstirred water layer. We have developed an artificial octanol membrane that is cheap and simple to prepare. The novel membrane consists of a hydrated semi-permeable cellophane membrane with a molecular weight cut off (MWCO) of 12,000–14,000 that mimics the unstirred water layer and a lipophilic membrane of pure n-octanol in a nitrocellulose matrix. The membrane was used to investigate the effects of 2-hydroxypropyl-β-cyclodextrin (HPβCD) on the flux of hydrocortisone through the membrane. In aqueous HPβCD saturated with hydrocortisone the drug concentration gradient, over the unstirred water layer, increased with increasing HPβCD concentration which resulted in enhanced drug delivery through the membrane. When excess HPβCD was present in the donor phase the octanol/water partition coefficient decreased with increasing HPβCD concentration that lead to decreased drug delivery through the membrane.

Keywords

Octanol membrane Flux Unstirred water layer Cyclodextrin Formulation 

References

  1. 1.
    Lipinski, C.A., Lombardo, F., Dominy, B.W., Feeney, P.J.: Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46, 3–26 (2001)CrossRefGoogle Scholar
  2. 2.
    Amidon, G.L., Lennernäs, H., Shah, V.P., Crison, J.R.: A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12, 413–420 (1995)CrossRefGoogle Scholar
  3. 3.
    Loftsson, T., Masson, M.: Cyclodextrins in topical drug formulations: theory and practice. Int. J. Pharm. 225, 15–30 (2001)CrossRefGoogle Scholar
  4. 4.
    Sinha, V.R., Bindra, S., Kumria, R., Nanda, A.: Cyclodextrin as skin-penetration enhancers. Pharm. Technol. 27(3), 120–138 (2003)Google Scholar
  5. 5.
    Loftsson, T., Konráðsdóttir, F., Másson, M.: Influence of aqueous diffusion layer on passive drug diffusion from aqueous cyclodextrin solutions through biological membranes. Pharmazie 61, 83–89 (2006)Google Scholar
  6. 6.
    Loftsson, T., Sigfússon, S.D., Sigurðsson, H.H., Másson, M.: The effects of cycodextrins on topical delivery of hydrocortisone: the aqueous diffusion layer. S.T.P. Pharma Sci. 13, 125–131 (2003)Google Scholar
  7. 7.
    Loftsson, T., Konrádsdóttir, F., Másson M.: Development and evaluation of an artificial membrane for determination of drug availability in pharmaceutical formulations. Int. J. Pharm., 326, 60–68 (2006)CrossRefGoogle Scholar
  8. 8.
    Másson, M., Sigurdardóttir, B.V., Matthíasson, K., Loftsson, T.: Investigation of drug-cyclodextrin complexes by a phase-distribution method: some theoretical and practical considerations. Chem. Pharm. Bull. 53, 958–964 (2005)CrossRefGoogle Scholar
  9. 9.
    Masson, M., Loftsson, T., Masson, G., Stefansson, E.: Cyclodextrins as permeation enhancers: some theoretical evaluations and in vitro testing. J. Control. Rel. 59, 107–118 (1999)CrossRefGoogle Scholar
  10. 10.
    Loftsson, T., Sigurdardottir, A.M.: The effect of polyvinypyrrolidone and hydroxylpropyl methylcellulose on HPβCD complexation of hydrocortisone and its permeability through hairless mouse skin. Eur. J. Pharm. Sci. 2, 297–301 (1994)CrossRefGoogle Scholar
  11. 11.
    Williams, A.C., Barry, B.W.: Penetration enhancers. Adv. Drug Deliv. Rev. 56, 603–618 (2004)CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2007

Authors and Affiliations

  • Thorsteinn Loftsson
    • 1
  • Fífa Konrádsdóttir
    • 1
  • Már Másson
    • 1
  1. 1.Faculty of PharmacyUniversity of IcelandReykjavikIceland

Personalised recommendations